Establishment of a diabetic mouse model with progressive diabetic nephropathy.

[1]  S. Bonner-Weir,et al.  Induced ICER Iγ down-regulates cyclin A expression and cell proliferation in insulin-producing β cells , 2005 .

[2]  J. Miyazaki,et al.  Overexpression of Inducible Cyclic AMP Early Repressor Inhibits Transactivation of Genes and Cell Proliferation in Pancreatic β Cells , 2004, Molecular and Cellular Biology.

[3]  Li-jun Ma,et al.  Model of robust induction of glomerulosclerosis in mice: importance of genetic background. , 2003, Kidney international.

[4]  S. Riley,et al.  Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. , 2003, Kidney international.

[5]  D. Yue,et al.  High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. , 2003, Atherosclerosis.

[6]  Kumar Sharma,et al.  Diabetic kidney disease in the db/db mouse. , 2003, American journal of physiology. Renal physiology.

[7]  T. Kita,et al.  Growth Arrest-specific Gene 6 Is Involved in Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy* , 2003, The Journal of Biological Chemistry.

[8]  M. Burnier,et al.  Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes. , 2002, Journal of the American Society of Nephrology : JASN.

[9]  G. Striker,et al.  Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background. , 2002, Diabetes.

[10]  S. Takasawa,et al.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. , 2001, The Journal of clinical investigation.

[11]  T. Yokozawa,et al.  Animal model of diabetic nephropathy. , 2001, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[12]  Yuichiro Yamada,et al.  The Cyclic AMP Response Element Modulator Family Regulates the Insulin Gene Transcription by Interacting with Transcription Factor IID* , 1999, The Journal of Biological Chemistry.

[13]  G. Striker,et al.  Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. , 1999, The American journal of pathology.

[14]  E. Ritz,et al.  Renal disease and hypertension in non-insulin-dependent diabetes mellitus. , 1999, Kidney international.

[15]  K. Tsuda,et al.  Transcriptional repressors are increased in pancreatic islets of type 2 diabetic rats. , 1998, Biochemical and biophysical research communications.

[16]  G. Boivin,et al.  Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. , 1998, American journal of physiology. Renal physiology.

[17]  G. Striker,et al.  Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. , 1998, Kidney international.

[18]  G. Gambaro,et al.  Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM , 1997, Diabetologia.

[19]  P. Eggers,et al.  Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. , 1996, Kidney international.

[20]  T. Kita,et al.  Advanced glycation end products modulate transcriptional regulation in mesangial cells. , 1996, Kidney international.

[21]  G. Striker,et al.  Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. , 1996, The Journal of clinical investigation.

[22]  J Ludvigsson,et al.  Declining incidence of nephropathy in insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[23]  Rudolfs K. Zalups.  The Os/+ mouse: a genetic animal model of reduced renal mass. , 1993, The American journal of physiology.

[24]  E. Borrelli,et al.  CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription , 1991, Cell.

[25]  G. Striker,et al.  Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[26]  O. E. Michaelis,et al.  Animal models of spontaneous diabetic kidney disease , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Flier,et al.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.

[28]  C. Kilo,et al.  Increased Vascular Permeability in Spontaneously Diabetic BB/W Rats and in Rats With Mild Versus Severe Streptozocin-Induced Diabetes: Prevention by Aldose Reductase Inhibitors and Castration , 1987, Diabetes.

[29]  Y. Tochino.  The NOD mouse as a model of type I diabetes. , 1987, Critical reviews in immunology.

[30]  B. Brenner,et al.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Y. Kanwar,et al.  Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. B. Jensen,et al.  Determination of membrane thickness distribution from orthogonal intercepts , 1979, Journal of microscopy.

[33]  W. R. Hatrick.  On Diabetes , 1862, Glasgow medical journal.